Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) Research & Development: ₺0 Mil (TTM As of Mar. 2026)


IST:SELEC Selcuk Ecza Deposu Ticaret ve Sanayi AS IST:SELEC
79 GF Score
Price ₺198.30
GF Value ₺86.35
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Selcuk Ecza Deposu Ticaret venayi AS Research & Development?

Selcuk Ecza Deposu Ticaret venayi AS IST:SELEC -7.72% 79 Research & Development is ₺0 Mil as of Mar. 2026. GuruFocus rates IST:SELEC with a GF Score™ of 79/100 and a GF Value™ of ₺86.35 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Selcuk Ecza Deposu Ticaret venayi AS's Research & Development for the three months ended in Mar. 2026 was ₺0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₺0 Mil.

Selcuk Ecza Deposu Ticaret venayi AS  (IST:SELEC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Selcuk Ecza Deposu Ticaret venayi AS Research & Development Related Terms

Selcuk Ecza Deposu Ticaret venayi AS Research & Development Historical Data

* Premium members only.

The historical data trend for Selcuk Ecza Deposu Ticaret venayi AS's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Selcuk Ecza Deposu Ticaret venayi AS Research & Development Chart

Selcuk Ecza Deposu Ticaret venayi AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Selcuk Ecza Deposu Ticaret venayi AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
IST:SELEC
79GF Score
Selcuk Ecza Deposu Ticaret ve Sanayi AS IST:SELEC
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Selcuk Ecza Deposu Ticaret venayi AS Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₺0 Mil mean?
Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) has a Research & Development of ₺0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors.
Is Selcuk Ecza Deposu Ticaret venayi AS's Research & Development too high?
Selcuk Ecza Deposu Ticaret venayi AS's current Research & Development is ₺0 Mil. Overall, Selcuk Ecza Deposu Ticaret venayi AS has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selcuk Ecza Deposu Ticaret venayi AS's Research & Development compare to MCK and COR?
Selcuk Ecza Deposu Ticaret venayi AS's Research & Development of ₺0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Distribution company?
A good Research & Development depends on the Medical Distribution industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors. Selcuk Ecza Deposu Ticaret venayi AS's current Research & Development is ₺0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selcuk Ecza Deposu Ticaret venayi AS stock overvalued right now?
Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺86.35, compared to a current price of ₺198.30 — trading 129.6% above its estimated fair value. The current Research & Development is ₺0 Mil. Selcuk Ecza Deposu Ticaret venayi AS's overall GF Score™ is 79/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC), the current Research & Development is ₺0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) Overvalued in 2026?

Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS stock appears to be overvalued. The current stock price of ₺198.30 is trading 129.6% above its estimated GF Value™ of ₺86.35. GuruFocus considers Selcuk Ecza Deposu Ticaret venayi AS to be Significantly Overvalued.

Key valuation signals for IST:SELEC:

  • Research & Development: ₺0 Mil
  • GF Value™: ₺86.35 vs. price of ₺198.30 (129.6% above fair value)
  • GF Score™: 79/100 with 9 warning signs

No single metric tells the full story. See the IST:SELEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Selcuk Ecza Deposu Ticaret venayi AS Business Description

Address Altunizade Mah. Kusbakisi Cad. No: 37, Nakkastepe, Istanbul, TUR, 34662
Selcuk Ecza Deposu Ticaret ve Sanayi AS and its subsidiaries are in the business of export and import of drugs and patent medicines, medical supplies with pharmacy depot operations and also organize distribution channels between drug manufacturers, hospitals, and pharmacies. The company also distributes cosmetics, personal care, infant food, vitamins, medical and similar products.
79GF Score

Get the complete analysis for IST:SELEC

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺198.30
Price
₺86.35
GF Value